{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:57:52Z","timestamp":1773435472262,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03601-0","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T17:33:58Z","timestamp":1737394438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The cardiometabolic safety of dupilumab in atopic dermatitis: A global large-scale cohort study"],"prefix":"10.1007","volume":"317","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Abdelghaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"3601_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13946","author":"N Stefanovic","year":"2020","unstructured":"Stefanovic N, Flohr C, Irvine AD (2020) The exposome in atopic dermatitis. Allergy: Europ J Allergy Clin Immunol. https:\/\/doi.org\/10.1111\/all.13946","journal-title":"Allergy: Europ J Allergy Clin Immunol"},{"issue":"10247","key":"3601_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. The Lancet 396(10247):345\u2013360. https:\/\/doi.org\/10.1016\/S0140-6736(20)31286-1","journal-title":"The Lancet"},{"key":"3601_CR3","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1136\/BMJ.K1786","volume":"361","author":"RJ Silverwood","year":"2018","unstructured":"Silverwood RJ, Forbes HJ, Abuabara K et al (2018) Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ 361:1786. https:\/\/doi.org\/10.1136\/BMJ.K1786","journal-title":"BMJ"},{"key":"3601_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.08.007","author":"J Wan","year":"2023","unstructured":"Wan J, Fuxench ZCC, Wang S et al (2023) Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis. J Allergy Clin Immunol In Pract. https:\/\/doi.org\/10.1016\/j.jaip.2023.08.007","journal-title":"J Allergy Clin Immunol In Pract."},{"issue":"5","key":"3601_CR5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/J.JACI.2018.11.030","volume":"143","author":"A Ascott","year":"2019","unstructured":"Ascott A, Mulick A, Yu AM et al (2019) Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies. J Allergy Clin Immunol 143(5):1821\u20131829. https:\/\/doi.org\/10.1016\/J.JACI.2018.11.030","journal-title":"J Allergy Clin Immunol"},{"issue":"24","key":"3601_CR6","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/nejmoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E et al (2016) Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med 375(24):2335\u20132348. https:\/\/doi.org\/10.1056\/nejmoa1610020","journal-title":"N Engl J Med"},{"issue":"10086","key":"3601_CR7","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","volume":"389","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt A, de Bruin-Weller M, Gooderham M et al (2017) Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. The Lancet 389(10086):2287\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(17)31191-1","journal-title":"The Lancet"},{"issue":"26","key":"3601_CR8","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMOA1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID et al (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378(26):2486\u20132496. https:\/\/doi.org\/10.1056\/NEJMOA1804092","journal-title":"N Engl J Med"},{"issue":"2","key":"3601_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3348\/KJR.2015.16.2.286","volume":"16","author":"S Baek","year":"2015","unstructured":"Baek S, Park SH, Won E, Park YR, Kim HJ (2015) Propensity Score Matching: A Conceptual Review for Radiology Researchers. Korean J Radiol 16(2):286. https:\/\/doi.org\/10.3348\/KJR.2015.16.2.286","journal-title":"Korean J Radiol"},{"issue":"6","key":"3601_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/SIM.6004","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC (2014) A comparison of 12 algorithms for matching on the propensity score. Stat Med 33(6):1057. https:\/\/doi.org\/10.1002\/SIM.6004","journal-title":"Stat Med"},{"issue":"5","key":"3601_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/ALL.13085","volume":"72","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Andersen YMF, Gislason GH, Skov L, Thyssen JP (2017) Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis. Allergy 72(5):783\u2013791. https:\/\/doi.org\/10.1111\/ALL.13085","journal-title":"Allergy"},{"issue":"1","key":"3601_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/J.JACI.2018.08.022","volume":"143","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E, Bissonnette R, Ungar B et al (2019) Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol 143(1):155\u2013172. https:\/\/doi.org\/10.1016\/J.JACI.2018.08.022","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3601_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/J.JACI.2014.11.023","volume":"135","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI, Greenland P (2015) Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 135(3):721-728.e6. https:\/\/doi.org\/10.1016\/J.JACI.2014.11.023","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"3601_CR14","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1111\/ALL.14859","volume":"76","author":"AP Villani","year":"2021","unstructured":"Villani AP, Pavel AB, Wu J et al (2021) Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response. Allergy 76(10):3107\u20133121. https:\/\/doi.org\/10.1111\/ALL.14859","journal-title":"Allergy"},{"key":"3601_CR15","doi-asserted-by":"publisher","DOI":"10.2340\/ACTADV.V103.5320","author":"GW Lee","year":"2023","unstructured":"Lee GW, Kim K, Kim SJ et al (2023) Therapeutic effect of dupilumab on systemic and vascular inflammation in adults with severe atopic dermatitis: feasibility study using 18f-fluorodeoxyglucose positron emission tomography-computed tomography. Acta Derm Venereol. https:\/\/doi.org\/10.2340\/ACTADV.V103.5320","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"3601_CR16","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1007\/S13555-023-01016-9\/FIGURES\/6","volume":"13","author":"MJ Cork","year":"2023","unstructured":"Cork MJ, Tha\u00e7i D, Eichenfield LF et al (2023) Dupilumab safety and efficacy in a phase iii open-label extension trial in children 6\u201311 years of age with severe atopic dermatitis. Dermatol Ther (Heidelb) 13(11):2697\u20132719. https:\/\/doi.org\/10.1007\/S13555-023-01016-9\/FIGURES\/6","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"9","key":"3601_CR17","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/S13555-022-00778-Y\/TABLES\/7","volume":"12","author":"J Cather","year":"2022","unstructured":"Cather J, Young M, DiRuggiero DC, Tofte S, Williams L, Gonzalez T (2022) A review of phase 3 trials of dupilumab for the treatment of atopic dermatitis in adults, adolescents, and children aged 6 and up. Dermatol Ther (Heidelb) 12(9):2013\u20132038. https:\/\/doi.org\/10.1007\/S13555-022-00778-Y\/TABLES\/7","journal-title":"Dermatol Ther (Heidelb)"},{"key":"3601_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/JAMADERMATOL.2024.1536","author":"LA Beck","year":"2024","unstructured":"Beck LA, Bissonnette R, Deleuran M et al (2024) Dupilumab in adults with moderate to severe atopic dermatitis: a 5-year open-label extension study. JAMA Dermatol. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2024.1536","journal-title":"JAMA Dermatol"},{"issue":"25","key":"3601_CR19","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMOA2205982\/SUPPL_FILE\/NEJMOA2205982_DATA-SHARING.PDF","volume":"387","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Rothenberg ME, Collins MH et al (2022) Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med 387(25):2317\u20132330. https:\/\/doi.org\/10.1056\/NEJMOA2205982\/SUPPL_FILE\/NEJMOA2205982_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"issue":"10039","key":"3601_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S, Castro M, Corren J et al (2016) Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet 388(10039):31\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(16)30307-5","journal-title":"Lancet"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03601-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T17:34:01Z","timestamp":1737394441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03601-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3601"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03601-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"296"}}